Fig. 2.

Experimental validation of ENO1 and PKM expression changes in HBV-related HCC. (A-B) Immunohistochemistry of clinical tissues implied the enhanced ENO1 (A) and PKM (B) expression in HCC tissues of patients, especially in HBV-infected HCC tissues. (C-D) Western blot demonstrated the up-regulated proteins for ENO1 and PKM proteins in HCC tissues of patients, especially in HBV-infected HCC tissues. *** P < 0.001 vs. Normal liver tissues. ### P < 0.001 vs. HCC tissues. (E) qRT-PCR revealed the increased expression of ENO1 (D) and PKM (E) mRNAs in HCC tissues of patients, especially in HBV-infected HCC tissues. *** P < 0.001 vs. Normal liver tissues. ### P < 0.001 vs. HCC tissues. (F) Western blot showed the elevated expression of HBc protein in HCC tissues of patients, especially in HBV-infected HCC tissues. *** P < 0.001 vs. Normal liver tissues. ### P < 0.001 vs. HCC tissues. (G-H) Pearson’s correlation analysis displayed positive correlations between ENO1 and HBc (G), as well as between PKM and HBc (H) in HBV-infected HCC tissues. (I-K) qRT-PCR (I) along with Western blot (J, K) indicated the abnormally increased expression of ENO1 and PKM in HCC cells (HepG2), especially in HBV-infected HCC cells (HepG2.2.15). *** P < 0.001 vs. human normal hepatocytes (THLE-2). ### P < 0.001 vs. HCC cells (HepG2)